+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Human OCT1 bound to diltiazem in inward-open conformation | |||||||||
Map data | Human OCT1 bound to diltiazem in inward-open conformation | |||||||||
Sample |
| |||||||||
Keywords | membrane protein / MFS / drug transporter / TRANSPORT PROTEIN | |||||||||
| Function / homology | Function and homology informationacetylcholine transport / (R)-carnitine transmembrane transporter activity / O-acyl-L-carnitine transmembrane transport / pyrimidine nucleoside transmembrane transporter activity / serotonin transport / spermidine transmembrane transporter activity / quaternary ammonium group transmembrane transporter activity / epinephrine transport / purine-containing compound transmembrane transport / putrescine transmembrane transporter activity ...acetylcholine transport / (R)-carnitine transmembrane transporter activity / O-acyl-L-carnitine transmembrane transport / pyrimidine nucleoside transmembrane transporter activity / serotonin transport / spermidine transmembrane transporter activity / quaternary ammonium group transmembrane transporter activity / epinephrine transport / purine-containing compound transmembrane transport / putrescine transmembrane transporter activity / quaternary ammonium group transport / SLC-mediated transport of organic cations / acetylcholine transmembrane transporter activity / organic cation transport / spermidine transport / : / dopamine uptake / putrescine transport / thiamine transmembrane transport / thiamine transmembrane transporter activity / thiamine transport / norepinephrine:sodium symporter activity / metanephric proximal tubule development / toxin transmembrane transporter activity / norepinephrine transport / dopamine:sodium symporter activity / prostaglandin transport / Norepinephrine Neurotransmitter Release Cycle / Abacavir transmembrane transport / prostaglandin transmembrane transporter activity / neurotransmitter transmembrane transporter activity / serotonin uptake / establishment or maintenance of transmembrane electrochemical gradient / dopamine transport / Neurotransmitter clearance / xenobiotic transport across blood-brain barrier / monoamine transmembrane transporter activity / monoamine transport / : / Ciprofloxacin ADME / SLC-mediated transport of neurotransmitters / cellular detoxification / xenobiotic transport / neurotransmitter transport / lateral plasma membrane / xenobiotic transmembrane transporter activity / transport across blood-brain barrier / xenobiotic metabolic process / basal plasma membrane / presynapse / basolateral plasma membrane / apical plasma membrane / identical protein binding / membrane / plasma membrane Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.36 Å | |||||||||
Authors | Zeng YC / Sobti M / Stewart AG | |||||||||
| Funding support | Australia, 1 items
| |||||||||
Citation | Journal: Nat Commun / Year: 2023Title: Structural basis of promiscuous substrate transport by Organic Cation Transporter 1. Authors: Yi C Zeng / Meghna Sobti / Ada Quinn / Nicola J Smith / Simon H J Brown / Jamie I Vandenberg / Renae M Ryan / Megan L O'Mara / Alastair G Stewart / ![]() Abstract: Organic Cation Transporter 1 (OCT1) plays a crucial role in hepatic metabolism by mediating the uptake of a range of metabolites and drugs. Genetic variations can alter the efficacy and safety of ...Organic Cation Transporter 1 (OCT1) plays a crucial role in hepatic metabolism by mediating the uptake of a range of metabolites and drugs. Genetic variations can alter the efficacy and safety of compounds transported by OCT1, such as those used for cardiovascular, oncological, and psychological indications. Despite its importance in drug pharmacokinetics, the substrate selectivity and underlying structural mechanisms of OCT1 remain poorly understood. Here, we present cryo-EM structures of full-length human OCT1 in the inward-open conformation, both ligand-free and drug-bound, indicating the basis for its broad substrate recognition. Comparison of our structures with those of outward-open OCTs provides molecular insight into the alternating access mechanism of OCTs. We observe that hydrophobic gates stabilize the inward-facing conformation, whereas charge neutralization in the binding pocket facilitates the release of cationic substrates. These findings provide a framework for understanding the structural basis of the promiscuity of drug binding and substrate translocation in OCT1. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_40335.map.gz | 59.7 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-40335-v30.xml emd-40335.xml | 17.4 KB 17.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_40335_fsc.xml | 8.4 KB | Display | FSC data file |
| Images | emd_40335.png | 99.5 KB | ||
| Filedesc metadata | emd-40335.cif.gz | 6.3 KB | ||
| Others | emd_40335_half_map_1.map.gz emd_40335_half_map_2.map.gz | 59.5 MB 59.5 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-40335 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-40335 | HTTPS FTP |
-Validation report
| Summary document | emd_40335_validation.pdf.gz | 747.5 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_40335_full_validation.pdf.gz | 747.1 KB | Display | |
| Data in XML | emd_40335_validation.xml.gz | 16.1 KB | Display | |
| Data in CIF | emd_40335_validation.cif.gz | 20.9 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-40335 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-40335 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 8sc2MC ![]() 8sc1C ![]() 8sc3C ![]() 8sc4C ![]() 8sc6C M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_40335.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Human OCT1 bound to diltiazem in inward-open conformation | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.84 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: Half Map 1
| File | emd_40335_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map 1 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half Map 2
| File | emd_40335_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map 2 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Human OCT1
| Entire | Name: Human OCT1 |
|---|---|
| Components |
|
-Supramolecule #1: Human OCT1
| Supramolecule | Name: Human OCT1 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Solute carrier family 22 member 1
| Macromolecule | Name: Solute carrier family 22 member 1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 59.167422 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: KQAFLILCLL SAAFAPICVG IVFLGFTPDH HCQSPGVAEL SQRCGWSPAE ELNYTVPGLG PAGEAFLGQC RRYEVDWNQS ALSCVDPLA SLATNRSHLP LGPCQDGWVY DTPGSSIVTE FNLVCADSWK LDLFQSCLNA GFLFGSLGVG YFADRFGRKL C LLGTVLVN ...String: KQAFLILCLL SAAFAPICVG IVFLGFTPDH HCQSPGVAEL SQRCGWSPAE ELNYTVPGLG PAGEAFLGQC RRYEVDWNQS ALSCVDPLA SLATNRSHLP LGPCQDGWVY DTPGSSIVTE FNLVCADSWK LDLFQSCLNA GFLFGSLGVG YFADRFGRKL C LLGTVLVN AVSGVLMAFS PNYMSMLLFR LLQGLVSKGN WMAGYTLITE FVGSGSRRTV AIMYQMAFTV GLVALTGLAY AL PHWRWLQ LAVSLPTFLF LLYYWCVPES PRWLLSQKRN TEAIKIMDHI AQKNGKLPPA DLKMLSLEED VTEKLSPSFA DLF RTPRLR KRTFILMYLW FTDSVLYQGL ILHMGATSGN LYLDFLYSAL VEIPGAFIAL ITIDRVGRIY PMAMSNLLAG AACL VMIFI SPDLHWLNII IMCVGRMGIT IAIQMICLVN AELYPTFVRN LGVMVCSSLC DIGGIITPFI VFRLREVWQA LPLIL FAVL GLLAAGVTLL LPETKGVALP ETMKDAENLG RKAKPKENTI YLKVQTSEPS GT UniProtKB: Solute carrier family 22 member 1 |
-Macromolecule #2: Diltiazem
| Macromolecule | Name: Diltiazem / type: ligand / ID: 2 / Number of copies: 1 / Formula: C9F |
|---|---|
| Molecular weight | Theoretical: 414.518 Da |
| Chemical component information | ![]() ChemComp-C9F: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 8 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | FEI TITAN KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 88.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.5 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi




Keywords
Homo sapiens (human)
Authors
Australia, 1 items
Citation














Z (Sec.)
Y (Row.)
X (Col.)





































Processing
FIELD EMISSION GUN

